Aarkstore 2012 The Latest Reports || Orphan Autoimmune Disorders to 2017 - Strong Performance

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) February 16, 2012 -- RSS Aarkstore.com announces, a new market research report is available in its vast collection:

Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market

http://www.aarkstore.com/reports/Orphan-Autoimmune-Disorders-to-2017-Strong-Performance-by-Nplate-and-Promacta-and-Future-Launches-of-Immunoglobulin-Therapies-will-Drive-the-ITP-Market-170858.html




Summary

Company’s report, “Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market” provides in-depth analysis of the drivers and barriers that affect the global orphan autoimmune disorders. The report analyzes the markets for orphan autoimmune disorders therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2017 for the leading therapeutic segments. The report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Company’s team of industry experts.

Scope :

- Annualized market data for the orphan autoimmune disorders therapeutics market from 2002 to 2010, and forecast to 2017.
- Analysis of the leading therapeutic segments. These include ITP, myasthenia gravis and ALS.

- Analysis of the orphan autoimmune disorders therapeutic markets in the leading geographies of the world, which include the US, top five countries of Europe and Japan.
- Market characterization of the orphan autoimmune disorders (ITP, myasthenia gravis and ALS) market including market size, revenue analysis by top seven geographies, generic share, annual cost of therapy, and treatment usage patterns.



Table of Contents :

1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Orphan Autoimmune Disorders to 2017 - Introduction 9
2.1 Overview 9
2.2 GBI Research Report Guidance 10
3 Orphan Autoimmune Disorders to 2017 - Market Characterization 11
3.1 Market Forecasts 11

3.1.1 Revenue 11
3.1.2 Market Share of Orphan Diseases 13
3.1.3 Generic/Off-Label Share 14
3.2 Drivers and Restraints for the Global Orphan Autoimmune Disorders Therapeutics Market 15
3.2.1 Market Drivers 15
3.2.2 Market Restraints 15

For more related Reports Plz follow The link:
http://www.aarkstore.com/reports/Renal-Dialysis-Services-Global-Opportunity-Assessment-Competitive-Landscape-and-Market-Forecasts-to-2017-170022.html

http://www.aarkstore.com/reports/Transcatheter-Heart-Valve-Market-to-2017-Improvements-in-Design-and-Technique-and-a-Favorable-Reimbursement-Scenario-to-Contribute-to-Higher-Procedure-Volumes-178255.html

http://www.aarkstore.com/reports/Endpoints-Clinical-Trials-in-CNS-Disorders-Multiple-Endpoints-and-Ratings-Scales-are-Becoming-More-Widely-Adopted-170853.html





For More details Plz do contact :

Aarkstore Enterprise

Phone:08149852585

Email: enquiry@aarkstore.com

OrphanAutoimmuneDisordersStron